Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Beta Bionics (BBNX) Retained Earnings (2023 - 2025)

Beta Bionics (BBNX) has disclosed Retained Earnings for 3 consecutive years, with -$369.9 million as the latest value for Q4 2025.

  • Quarterly Retained Earnings fell 569233.85% to -$369.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$369.9 million through Dec 2025, down 569233.85% year-over-year, with the annual reading at -$369.9 million for FY2025, 569233.85% down from the prior year.
  • Retained Earnings hit -$369.9 million in Q4 2025 for Beta Bionics, down from -$356.5 million in the prior quarter.
  • In the past five years, Retained Earnings ranged from a high of $137000.0 in Q4 2023 to a low of -$369.9 million in Q4 2025.
  • Historically, Retained Earnings has averaged -$232.3 million across 3 years, with a median of -$333.8 million in 2025.
  • Biggest five-year swings in Retained Earnings: crashed 52.55% in 2024 and later tumbled 569233.85% in 2025.
  • Year by year, Retained Earnings stood at $137000.0 in 2023, then plummeted by 52.55% to $65000.0 in 2024, then crashed by 569233.85% to -$369.9 million in 2025.
  • Business Quant data shows Retained Earnings for BBNX at -$369.9 million in Q4 2025, -$356.5 million in Q3 2025, and -$342.3 million in Q2 2025.